Skip to main content
Log in

Abnormal Tau proteins in progressive supranuclear palsy

Similarities and differences with the neurofibrillary degeneration of the Alzheimer type

  • Regular Papers
  • Published:
Acta Neuropathologica Aims and scope Submit manuscript

Summary

We have previously shown that abnormal Tau species are produced during the neurofibrillary degeneration of the Alzheimer type. These abnormal Tau proteins consist of a characteristic triplet named Tau 55, Tau 64 and Tau 69 which are constantly found in Alzheimer's disease (AD) and Downs syndrome brain regions with tangles. To determine if abnormal Tau species are also produced in other neurodegenerative conditions where intraneuronal filamentous Tau aggregates are observed, we have undertaken an immuno-blot study of brain homogenates from patients with progressive supranuclear palsy (PSP), a neurological disorder characterized by the presence of tangles in subcortical and cortical brain areas. We show here that abnormal Tau species are produced in PSP but that they are different from those in AD. Indeed, although Tau 64 and 69 were present in PSP brain homogenates, possibly as the result of an abnormal phosphorylation as in AD, they were detected in smaller amounts (three times lower) than in AD. In addition Tau 55 was undetected by the immunological tools, such as the absorbed anti-PHF antisera, which specifically label the abnormal Tau proteins. Also the two-dimensional analysis revealed different isoelectric properties. Our results suggest that the production of abnormal Tau species is a very important event during all types of neurofibrillary degeneration. The differences in the pathological Tau-variant profile that were observed between PSP and AD possibly reflect different etiopathogenetic pathways and might explain the formation of different types of filamentous Tau aggregates.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bancher C, Lassmann H, Budka H, Grundke-Iqbal I, Iqbal K (1987) Neurofibrillary tangles in Alzheimer's disease and progressive supranuclear palsy: antigenic similarities and differences. Acta Neuropathol (Berl) 74:39–46

    Google Scholar 

  2. Brion JP, Passareiro H, Nunez J, Flament-Durand J (1985) Mise en évidence immunologique de la protéine Tau au niveau des lésions de dégénérescence neurofibrillaire de la maladie d'Alzheimer. Arch Biol 95:229–235

    Google Scholar 

  3. Defossez A, Beauvillain JC, Delacourte A, Mazzuca M (1988) Alzheimer's disease: a new evidence for common epitopes between microtubule-associated protein Tau and paired helical filaments (PHF): demonstration at the electron microscope by a double immunogold labelling. Virchows Arch 413:141–145

    Google Scholar 

  4. Delacourte A, Defossez A (1986) Alzheimer's disease: Tau proteins, the promoting factors of microtubule assembly, are major antigenic components of paired helical filaments. J Neurol Sci 76:173–186

    Google Scholar 

  5. Delacourte A, Flament S, Defossez A (1990) Towards the development of an in vitro study model of the Alzheimer-type neurofibrillary degeneration. Presse Méd 19:170–173

    Google Scholar 

  6. Delacourte A, Flament S, Dibe EM, Hublau P, Sablonniere B, Hemon B, Scherrer V, Defossez A (1990) Pathological proteins Tau 64 and 69 are specifically expressed in the somatodendritic domain of the degenerating cortical neurons during Alzheimer's disease: demonstration with a panel of antibodies against Tau proteins. Acta Neuropathol 80:111–117

    Google Scholar 

  7. Drubin DG, Kirshner MW (1986) Tau protein function in living cells. J Cell Biol 103:2739–2746

    Google Scholar 

  8. Emori CR, Ala TA, Frey WH (1987) Ganglioside monoclonal antibody (A2B5) labels Alzheimer's neurofibrillary tangles. Neurology 37:768–772

    Google Scholar 

  9. Flament S, Delacourte A (1990) Tau marker? Nature 346:22

    Google Scholar 

  10. Flament S, Delacourte A, Hemon B, Defossez A (1989) Characterization of two pathological Tau protein variants in Alzheimer brain cortices. J Neurol Sci 92:133–141

    Google Scholar 

  11. Flament S, Delacourte A, Delaere P, Duyckaerts C, Hauw J-J (1990) Correlation between microscopical changes and Tau 64 and 69 biochemical detection in senile dementia of the alzheimer type. Tau 64 and 69 are reliable markers of the neurofibrillary degeneration. Acta Neuropathol 80:212–215

    Google Scholar 

  12. Flament S, Delacourte A, Mann DMA (1990) Phosphorylation of Tau proteins: a major event during the process of neurofibrillary degeneration. Brain Res 516:15–19

    Google Scholar 

  13. Hauw J-J, Venry M, Delaere P, Cervera P, He Y, Duyckaerts C (1990) Constant neurofibrillary changes in progressive supranuclear palsy. Basic differences with Alzheimer's disease and aging. Neurosci Lett 119:182–186

    Google Scholar 

  14. Joachim CL, Morris JH, Kosik KS, Selkoe DJ (1987) Tau antisera recognize neurofibrillary tangles in a range of neurodegenerative disorders. Ann Neurol 22:514–520

    Google Scholar 

  15. Kidd M (1963) Paired helical filaments in electron microscopy of Alzheimer's disease. Nature 197:192–193

    Google Scholar 

  16. Laemmli UK (1970) Cleavage of structural proteins during head assembly of bacteriophage T4. Nature 227:680–685

    Google Scholar 

  17. Mori H, Konda J, Ihara Y (1987) Ubiquitin is a component of paired helical filaments in Alzheimer disease. Science 235:1641–1644

    Google Scholar 

  18. O'Farrell PH (1975) High-resolution two-dimensional electrophoresis of proteins. J Biol Chem 250:4007–4021

    Google Scholar 

  19. Pollock NJ, Mirra SS, Binder LI, Hansen LA, Wood JG (1986) Filamentous aggreagates in Pick's disease, progressive supranuclear palsy and Alzheimer's disease share antigenic determinant with microtubule-associated protein Tau. Lancet II:1211

    Google Scholar 

  20. Rewcastle NB, Ball MJ (1968) Electron microscopic structure of the “inclusion bodies” in Pick's disease. Neurology 18:1205–1213

    Google Scholar 

  21. Ruberg M, Javoy-Agid F, Hirsh E, Scatton B, Lheureux R, Hauw J-J, Duyckaerts C, Gray F, Morel-Maroger A, Rascol A, Serdaru M, Agid Y (1985) Dopaminergic and cholinergic lesions in progressive supranuclear palsy. Ann Neurol 18:523–529

    Google Scholar 

  22. Shibayama H, Kitoh J (1978) Electron microscopic structure of Alzheimer's neurofibrillary changes in a case of atypical senile dementia. Acta Neuropathol (Berl) 41:229–234

    Google Scholar 

  23. Steele JC (1972) Progressive supranuclear palsy. Brain 95:693–704

    Google Scholar 

  24. Steele JC, Ridchardson JC, Olszewski J (1964) Progressive supranuclear palsy. Arch Neurol 10:333–359

    Google Scholar 

  25. Takauchi S, Mizuhara T, Miyoshi K (1983) Unusual paired helical filaments in progressive supra nuclear palsy. Acta Neuropathol (Berl) 59:225–228

    Google Scholar 

  26. Tellez-Nagel I, Wisniewski HM (1973) Ultrastructure of neurofibrillary tangles in Steele-Ridchardson-Olszewski syndrome. Arch Neurol 29:324–327

    Google Scholar 

  27. Weingarten MD, Lockwood AH, Hwo SY, Kirschner MW (1975) A protein factor essential for microtubule assembly. Proc Natl Acad Sci USA 72:1858–1862

    Google Scholar 

  28. Wilson DL, Hall ME, Stone GC, Rubin RW (1977) Some improvements in two-dimensional gel electrophoresis of proteins. Anal Biochem 83:33–44

    Google Scholar 

  29. Wisniewski K, Jervis GA, Moretz RC, Wisniewski HM (1979) Alzheimer neurofibrillary tangles in disease other than senile and presenile dementia. Ann Neurol 5:288–294

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Supported by grants from MRES (88c 0710), CNMATS/INSERM, C.A.R. INSERM no. 489016

Rights and permissions

Reprints and permissions

About this article

Cite this article

Flament, S., Delacourte, A., Verny, M. et al. Abnormal Tau proteins in progressive supranuclear palsy. Acta Neuropathol 81, 591–596 (1991). https://doi.org/10.1007/BF00296367

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00296367

Key words

Navigation